Systems analysis of ATF3 in stress response and cancer reveals opposing effects on pro-apoptotic genes in p53 pathway

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Tanaka, Yujiro ^a   Nakamura, Aya ^a   Morioka, Masaki Suimye ^a   Inoue, Shoko ^a   Tamamori Adachi, Mimi ^a   Yamada, Kazuhiko ^a   Taketani, Kenji ^a   Kawauchi, Junya ^a   Tanaka Okamoto, Miki ^b   Miyoshi, Jun ^b   Tanaka, Hiroshi ^a   Kitajima, Shigetaka ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; INSULIN; MESYLIC ACID METHYL ESTER; PROTEIN P53; TRANSCRIPTION FACTOR; VASCULOTROPIN; WNT PROTEIN; APOPTOSIS REGULATORY PROTEIN; ATF3 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BBC3 GENE; BINDING SITE; CALCIUM SIGNALING; CDKN1A GENE; CELL ADHESION; CELL CYCLE; CELL STRAIN LNCAP; CONTROLLED STUDY; DIABETES MELLITUS; DR5 GENE; EMBRYO; GENE; GENE ACTIVATION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN GENOME; MALE; METABOLISM; MOUSE; NONHUMAN; P21 GENE; PROSTATE TUMOR; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MOTIF; PUMA GENE; SIGNAL TRANSDUCTION; STRESS; SYSTEM ANALYSIS; TNFRSF10B GENE; TRANSCRIPTION REGULATION; DNA DAMAGE; GENE REGULATORY NETWORK; GENETICS; NEOPLASM; OXIDATIVE STRESS; TUMOR CELL LINE;

ACTIVATING TRANSCRIPTION FACTOR 3; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; DNA DAMAGE; GENE REGULATORY NETWORKS; HUMANS; MALE; NEOPLASMS; OXIDATIVE STRESS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80055029836     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026848     Document Type: Article

References (56)

1. Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, et al. (1999) The transcriptional program in the response of human fibroblasts to serum. Science 283: 83-87.
2. Cho RJ, Huang M, Campbell MJ, Dong H, Steinmetz L, et al. (2001) Transcriptional regulation and function during the human cell cycle. Nat Genet 27: 48-54.
3. Gasch AP, Huang M, Metzner S, Botstein D, Elledge SJ, et al. (2001) Genomic expression responses to DNA-damaging agents and the regulatory role of the yeast ATR homolog Mec1p. Mol Biol Cell 12: 2987-3003.
4. Jelinsky SA, Samson LD, (1999) Global response of Saccharomyces cerevisiae to an alkylating agent. Proc Natl Acad Sci U S A 96: 1486-1491.
5. Workman CT, Mak HC, McCuine S, Tagne JB, Agarwal M, et al. (2006) A systems approach to mapping DNA damage response pathways. Science 312: 1054-1059.
6. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, et al. (2006) A global map of p53 transcription-factor binding sites in the human genome. Cell 124: 207-219.
7. Riley T, Sontag E, Chen P, Levine A, (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9: 402-412.
8. Zhao R, Gish K, Murphy M, Yin Y, Notterman D, et al. (2000) Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 14: 981-993.
9. Das S, Raj L, Zhao B, Kimura Y, Bernstein A, et al. (2007) Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation. Cell 130: 624-637.
10. Flores ER, Tsai KY, Crowley D, Sengupta S, Yang A, et al. (2002) p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 416: 560-564.
11. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, et al. (2000) p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102: 849-862.
12. Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, et al. (2006) Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 24: 841-851.
13. Tang Y, Luo J, Zhang W, Gu W, (2006) Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell 24: 827-839.
14. Hai TW, Liu F, Coukos WJ, Green MR, (1989) Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev 3: 2083-2090.
15. Chen BP, Wolfgang CD, Hai T, (1996) Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10. Mol Cell Biol 16: 1157-1168.
16. Hai T, Wolfgang CD, Marsee DK, Allen AE, Sivaprasad U, (1999) ATF3 and stress responses. Gene Expr 7: 321-335.
17. Gilchrist M, Thorsson V, Li B, Rust AG, Korb M, et al. (2006) Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441: 173-178.
18. Suganami T, Yuan X, Shimoda Y, Uchio-Yamada K, Nakagawa N, et al. (2009) Activating transcription factor 3 constitutes a negative feedback mechanism that attenuates saturated Fatty acid/toll-like receptor 4 signaling and macrophage activation in obese adipose tissue. Circ Res 105: 25-32.
19. Tamura K, Hua B, Adachi S, Guney I, Kawauchi J, et al. (2005) Stress response gene ATF3 is a target of c-myc in serum-induced cell proliferation. EMBO J 24: 2590-2601.
20. Pelzer AE, Bektic J, Haag P, Berger AP, Pycha A, et al. (2006) The expression of transcription factor activating transcription factor 3 in the human prostate and its regulation by androgen in prostate cancer. J Urol 175: 1517-1522.
21. Yin X, Dewille JW, Hai T, (2008) A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development. Oncogene 27: 2118-2127.
22. Janz M, Hummel M, Truss M, Wollert-Wulf B, Mathas S, et al. (2006) Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Sternberg cells. Blood 107: 2536-2539.
23. Amundson SA, Bittner M, Chen Y, Trent J, Meltzer P, et al. (1999) Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses. Oncogene 18: 3666-3672.
24. Fan F, Jin S, Amundson SA, Tong T, Fan W, et al. (2002) ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cells growth. Oncogene 21: 7488-7496.
25. Zhang C, Gao C, Kawauchi J, Hashimoto Y, Tsuchida N, et al. (2002) Transcriptional activation of the human stress-inducible transcriptional repressor ATF3 gene promoter by p53. Biochem Biophys Res Commun 297: 1302-1310.
26. Yan C, Lu D, Hai T, Boyd DD, (2005) Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. EMBO J 24: 2425-2435.
27. Ravasi T, Suzuki H, Cannistraci CV, Katayama S, Bajic VB, et al. (2010) An atlas of combinatorial transcriptional regulation in mouse and man. Cell 140: 744-752.
28. Kawauchi J, Zhang C, Nobori K, Hashimoto Y, Adachi MT, et al. (2002) Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-alpha-induced apoptosis through down-regulation of p53 transcription. J Biol Chem 277: 39025-39034.
29. Wu X, Nguyen BC, Dziunycz P, Chang S, Brooks Y, et al. (2010) Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature 465: 368-372.
30. Turchi L, Aberdam E, Mazure N, Pouyssegur J, Deckert M, et al. (2008) Hif-2alpha mediates UV-induced apoptosis through a novel ATF3-dependent death pathway. Cell Death Differ 15: 1472-1480.
31. Song JS, Johnson WE, Zhu X, Zhang X, Li W, et al. (2007) Model-based analysis of two-color arrays (MA2C). Genome Biol 8: R178.
32. Newman JR, Keating AE, (2003) Comprehensive identification of human bZIP interactions with coiled-coil arrays. Science 300: 2097-2101.
33. Mungrue IN, Pagnon J, Kohannim O, Gargalovic PS, Lusis AJ, (2009) CHAC1/MGC4504 is a novel proapoptotic component of the unfolded protein response, downstream of the ATF4-ATF3-CHOP cascade. J Immunol 182: 466-476.
34. Kiryu-Seo S, Kato R, Ogawa T, Nakagomi S, Nagata K, et al. (2008) Neuronal injury-inducible gene is synergistically regulated by ATF3, c-Jun, and STAT3 through the interaction with Sp1 in damaged neurons. J Biol Chem 283: 6988-6996.
35. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
36. Qi L, Saberi M, Zmuda E, Wang Y, Altarejos J, et al. (2009) Adipocyte CREB promotes insulin resistance in obesity. Cell Metab 9: 277-286.
37. Taketani K, Kawauchi J, Tanaka-Okamoto M, Ishizaki H, Tanaka Y, et al. (2011) Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells. Oncogene.
38. Yin X, Wolford CC, Chang YS, McConoughey SJ, Ramsey SA, et al. (2010) ATF3, an adaptive-response gene, enhances TGF{beta} signaling and cancer-initiating cell features in breast cancer cells. J Cell Sci 123: 3558-3565.
39. Bieda M, Xu X, Singer MA, Green R, Farnham PJ, (2006) Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. Genome Res 16: 595-605.
40. Bottone FG Jr, Moon Y, Alston-Mills B, Eling TE, (2005) Transcriptional regulation of activating transcription factor 3 involves the early growth response-1 gene. J Pharmacol Exp Ther 315: 668-677.
41. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, et al. (2009) Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459: 108-112.
42. Espinosa JM, (2008) Mechanisms of regulatory diversity within the p53 transcriptional network. Oncogene 27: 4013-4023.
43. Yan L, Della Coletta L, Powell KL, Shen J, Thames H, et al. (2011) Activation of the canonical Wnt/beta-catenin pathway in ATF3-induced mammary tumors. PLoS One 6: e16515.
44. Hackl C, Lang SA, Moser C, Mori A, Fichtner-Feigl S, et al. (2010) Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition. BMC Cancer 10: 668.
45. Allan AL, Albanese C, Pestell RG, LaMarre J, (2001) Activating transcription factor 3 induces DNA synthesis and expression of cyclin D1 in hepatocytes. J Biol Chem 276: 27272-27280.
46. Lu D, Wolfgang CD, Hai T, (2006) Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis. J Biol Chem 281: 10473-10481.
47. Rowland BD, Peeper DS, (2006) KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 6: 11-23.
48. Guo P, Dong XY, Zhao K, Sun X, Li Q, et al. (2009) Opposing effects of KLF5 on the transcription of MYC in epithelial proliferation in the context of transforming growth factor beta. J Biol Chem 284: 28243-28252.
49. Ruan K, Song G, Ouyang G, (2009) Role of hypoxia in the hallmarks of human cancer. J Cell Biochem 107: 1053-1062.
50. Gilbert LA, Hemann MT, (2011) Chemotherapeutic Resistance: Surviving Stressful Situations. Cancer Res.
51. Yoshida T, Maeda A, Tani N, Sakai T, (2001) Promoter structure and transcription initiation sites of the human death receptor 5/TRAIL-R2 gene. FEBS Lett 507: 381-385.
52. Daino K, Ichimura S, Nenoi M, (2006) Both the basal transcriptional activity of the GADD45A gene and its enhancement after ionizing irradiation are mediated by AP-1 element. Biochim Biophys Acta 1759: 458-469.
53. Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B, (2001) PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 7: 673-682.
54. Rittling SR, Baserga R, (1987) Functional analysis and growth factor regulation of the human vimentin promoter. Mol Cell Biol 7: 3908-3915.
55. Cai Y, Zhang C, Nawa T, Aso T, Tanaka M, et al. (2000) Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: activation of c-Jun NH(2)-terminal kinase and promoter response element. Blood 96: 2140-2148.
56. de Jonge HJ, Fehrmann RS, de Bont ES, Hofstra RM, Gerbens F, et al. (2007) Evidence based selection of housekeeping genes. PLoS One 2: e898.